Durable Response to Talimogene Laherparepvec (TVEC) Therapy in Advanced Melanoma

23 Visioni
Published
General Surgery Resident Dr. Baylee Bakilla presents "Durable Response to Talimogene Laherparepvec (TVEC) Therapy in Advanced Melanoma: Regional Therapy as an Adjunct or Replacement for Surgical Resection?" at Stanford Surgery's annual Holman Day celebration on May 9, 2025.

For more information about Stanford University's Department of Surgery, please visit our website: surgery.stanford.edu
Categoria
Oncology
Commenta per primo questo video.